None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients will be included in the study if they fulfill the following criteria: • Age of >19 years able to provide written informed consent • patient with 6-9 mm sized colorectal polyp
Exclusion criteria
Exclusion criteria: Patients will be excluded in the study if they fulfill the following criteria: • Age of <19 years • inable to provide written informed consent • patient with confirmed malignant polyp, suspected malignant polyp, previously incomplete resection polyp, subepithelial lesion • inflammatory bowel disease patients, uninterrupted antithrombotic therapy patients, coagulopathy patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| local recurrence rate as determined by endoscopic assessment (no visible recurrent polyps) and histological assessment (scar biopsies) on surveillance colonoscopy | — |
Secondary
| Measure | Time frame |
|---|---|
| en bloc resection rate; R0 resection rate;procedure time (measured as the time from the submucosal injection to complete removal of the polyp based on endoscopic assessment);intra-procedural and post-procedural adverse effect(immediate bleeding, delayed bleeding, immediate perforation, delayed perforation, post polypectomy syndrome) | — |
Countries
Korea, Republic of
Contacts
Hallym University Medical Center-Kangnam